Liver tells all and reveals truth about fat

April 20, 2012

Dr Barbara Fam from the University's Molecular Obesity Laboratory group at Austin Health with Associate Professor Sof Andrikopoulos have discovered that the liver can directly talk to the brain to control the amount of food we eat.

The results have demonstrated that the , which has never been classed as an important organ in controlling body weight before, is in fact a major player and should be considered a target for treatment of .

Test on mice showed that over-expression of a specific enzyme in the liver resulted in 50% less fat and the subjects ate less food than mice without the extra enzyme. Needed in the production of glucose, the enzyme called FBPase previously led to speculation that too much FBPase was bad for you.

'We actually thought that the mouse with the over-expressed enzyme would show signs of becoming diabetic since the enzyme is important in producing more glucose from the liver. However when we studied our mice in more depth, we were very surprised to see that this enzyme triggered a number of hormones that influence the control of appetite," said Dr Fam.

"The really striking result was that the genes in the brain, important in making us increase our were actually reduced.

"The results suggest that consumption of a high in fat, causes an increase in liver FBPase that was likely put in place as a negative feedback mechanism to limit further weight gain. Importantly, FBPase does not function to control body weight under normal physiological circumstances but acts only when the system is exposed to such as fat.

"When people eat diets loaded with fat and sugars particularly over the long term, it can have a number of different effects on the body but it appears that we actually have in place an innate system that protects us from any further weight gain that could happen while eating these type of diets."

More needs to be investigated to verify this in further trials, however this study has demonstrated that liver FBPase should be viewed not only as a mediator of metabolism but also as an important regulator of appetite and fat. It also gives us great insight into why the liver is a very important organ.

The study will be published in the Journal Diabetes in April.

Explore further: System in brain -- target of class of diabetes drugs -- linked to weight gain

Related Stories

System in brain -- target of class of diabetes drugs -- linked to weight gain

May 1, 2011
University of Cincinnati (UC) researchers have determined why a certain class of diabetes drugs leads to weight gain and have found that the molecular system involved (PPAR-γ found in the brain) is also triggered by ...

Enzyme boosts metabolism, prevents weight gain in mice

November 14, 2011
In a new study, scientists report that they substantially curbed weight gain, improved metabolism, and improved the efficacy of insulin in mice by engineering them to express a specific human enzyme in their fat tissue. Although ...

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.